BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST
Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed. Results of the basic clinical trials with BB (LIFE, ASCOT, etc.) are analyzed. The role of sympathetic system in different stages of cardiovascular continuum as well as forecast of BB clinical efficacy is s...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1144 |
_version_ | 1797232227462938624 |
---|---|
author | L. N. Malaj |
author_facet | L. N. Malaj |
author_sort | L. N. Malaj |
collection | DOAJ |
description | Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed. Results of the basic clinical trials with BB (LIFE, ASCOT, etc.) are analyzed. The role of sympathetic system in different stages of cardiovascular continuum as well as forecast of BB clinical efficacy is surveyed. Author presents a review of data about selective β1-blocker, metoprolol succinate (Betalok ZОК), in patients with cardiovascular diseases. |
first_indexed | 2024-03-08T14:03:03Z |
format | Article |
id | doaj.art-57c6af2e95c143e5b31295f305890741 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2024-04-24T15:56:55Z |
publishDate | 2016-01-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-57c6af2e95c143e5b31295f3058907412024-04-01T07:43:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0144858910.20996/1819-6446-2008-4-4-85-891143BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGISTL. N. Malaj0Medical and Sanitary Unit of Federal Security Service on Khabarovsk Territory, Frunze 123, 55, Khabarovsk, 680000 RussiaUsage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed. Results of the basic clinical trials with BB (LIFE, ASCOT, etc.) are analyzed. The role of sympathetic system in different stages of cardiovascular continuum as well as forecast of BB clinical efficacy is surveyed. Author presents a review of data about selective β1-blocker, metoprolol succinate (Betalok ZОК), in patients with cardiovascular diseases.https://www.rpcardio.online/jour/article/view/1144beta-blockersmetoprololcardiovascular diseases |
spellingShingle | L. N. Malaj BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Рациональная фармакотерапия в кардиологии beta-blockers metoprolol cardiovascular diseases |
title | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
title_full | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
title_fullStr | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
title_full_unstemmed | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
title_short | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
title_sort | beta adrenoblockers in xxi century epoch end or immortality beginning a view of ordinary cardiologist |
topic | beta-blockers metoprolol cardiovascular diseases |
url | https://www.rpcardio.online/jour/article/view/1144 |
work_keys_str_mv | AT lnmalaj betaadrenoblockersinxxicenturyepochendorimmortalitybeginningaviewofordinarycardiologist |